Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies

Sponsored by Chiesi Farmaceutici
Pharmacology
Other coronary interventions
Symposium
Room 252A

Anchorperson: Jolanta Siller-Matula

Spokesperson: Dominick Angiolillo

Discussants: Davide Cao, Guy Friedrich, Roxana Mehran, Jennifer Rymer

Watch this session if you want

  • To evaluate real-world evidence on antithrombotic strategies in clinical practice across Europe and USA
  • To analyse outcomes associated with the transition from cangrelor to oral P2Y12 inhibitors
  • To discuss implications of the findings on real-world evidence on state-of-the-art IV therapies in 2025
Welcome and session objectives

Jolanta Siller-Matula

Clinical case: urgent PCI on STEMI patient

Guy Friedrich

ARECA registry

Guy Friedrich

Discussion and audience interaction
Clinical case: a STEMI case presenting with cardiogenic shock

Jennifer Rymer

CAMEO registry

Jennifer Rymer

Discussion and audience interaction
Clinical case: timing and transition protocols to oral P2Y12s

Roxana Mehran

SMILE registry

Roxana Mehran

Discussion and audience interaction
Future insights: IV therapies in 2025

Davide Cao

Discussion and audience interaction
Session evaluation and key learnings

Dominick Angiolillo